AbbVie, Inc. (ABBV)
215.74
+2.62
(+1.23%)
USD |
NYSE |
May 27, 11:54
AbbVie Free Cash Flow : 19.98B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Biogen, Inc. | 2.316B |
| Gilead Sciences, Inc. | 10.23B |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Moderna, Inc. | -1.603B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.829B |
| Cash from Investing (Quarterly) | -574.00M |
| Cash from Financing (Quarterly) | 919.00M |
| Free Cash Flow Per Share (Quarterly) | 2.009 |
| Free Cash Flow to Equity (Quarterly) | -1.109B |
| Free Cash Flow to Firm (Quarterly) | 4.074B |
| Free Cash Flow Yield | 5.22% |